Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Go back to Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update| (NASDAQ: ODTX) | Delayed: 24.38 +1.16 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.22 | 52 Week High | $ | |||
| Open | $23.35 | 52 Week Low | $ | |||
| Day High | $25.15 | P/E | N/A | |||
| Day Low | $22.88 | EPS | $ | |||
| Volume | 2,604,396 | |||||

